MedPath
HSA Approval

DAPAGLIFLOZIN SANDOZ FILM COATED TABLET 10MG

SIN17199P

DAPAGLIFLOZIN SANDOZ FILM COATED TABLET 10MG

DAPAGLIFLOZIN SANDOZ FILM COATED TABLET 10MG

March 7, 2025

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

A10BK01

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Sandoz Private Limited

Active Ingredients

Dapagliflozin

10.000mg

Dapagliflozin

Documents

Package Inserts

Dapagliflozin Sandoz Film Coated Tablet 10mg PI.pdf

Approved: March 7, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DAPAGLIFLOZIN SANDOZ FILM COATED TABLET 10MG - HSA Approval | MedPath